-
Most Recent
Search Results
240 results for SSRI
Barneys New York and the Danger of Ignoring a Market Paradigm Shift
Barneys’ collapse shows how ignoring paradigm shifts destroys value. Investors face a similar market transition today.
Markets Change. Most Investors Don’t. That’s the Problem.
Most businesses don’t fail overnight. They fall behind quietly until one day, the damage is obvious. That’s exactly what happened to luxury fashion store Barneys…
Why Yesterday’s Winning Strategy Stops Working
In his piece today, Marc Chaikin shares the story of Barneys New York – a once-iconic retail powerhouse that looked untouchable… until the world changed…
This Iconic Retailer Failed to Adapt—Here’s How Investors Can Avoid the Same Fate
Today, Wall Street veteran Marc Chaikin is joining us to share why the stakes for investors right now may be higher than many realize.
Big Tech’s Earnings Are Exposing the True Cost of AI
In today’s Market 360, I’ll review four of the seven Magnificent Seven earnings that reported: Microsoft, Meta Platforms, Inc. (META), Tesla, Inc. (TSLA) and Apple…
Miss Out on Nvidia? Two More Innovative AI Chip Stocks Hiding in Plain Sight
Much like Nvidia at $72, these two AI chip stocks have incredible upside that Wall Street hasn’t fully realized yet…
CES 2026 Just Proved Why You Shouldn’t Buy AI Hype Stocks
Today, I’ll explain why investors shouldn’t be distracted by Big Tech’s bright lights… and show you where to find the actually valuable stocks that are…
3 Overlooked Trends Shaping 2026… and the 3 Stocks Positioned to Win
In this Sunday Digest, I’ll leave you with three trends that Wall Street’s Captain Hindsight has overlooked… and three stocks that should benefit as markets…
The Silicon Valley Supercycle
When it comes to wealth and investing, your portfolio needs to be built on a solid, sturdy foundation. In this special report, I will share…
Trump Soothes the Bull
This October Digest was a natural follow-up to the Crazy Map we shared yesterday – shifting from big-picture late-cycle dynamics to the practical question every…
4 Big Reasons to Buy Silver Standard Resources Inc. (USA) (SSRI) Stock After Earnings
Silver Standard Resources beat analyst’s expectations, yet the stock barely budged. Here are some more reasons for buying SSRI stock.
Will Silver Turn Things Around in 2015?
At this point, I believe SSRI is in a strong enough technical position to rebound to at least $7.47 without encountering much resistance.
5 Stocks With Superb Surprise — ASPN LOV GHDX SSRI FITB
This week, these five stocks have the best ratings in Surprise, one of the eight Fundamental Categories on Portfolio Grader.
5 Stocks With Prime Surprise — ASPN LOV SKT SSRI MSLI
This week, these five stocks have the best ratings in Surprise, one of the eight Fundamental Categories on Portfolio Grader.
5 Stocks With Superb Surprise — ASPN LOV SKT SSRI MSLI
This week, these five stocks have the best ratings in Surprise, one of the eight Fundamental Categories on Portfolio Grader.
Biggest Movers in Financial Stocks Now – MARA MDLY PLBC SSRI
The following stocks were the biggest movers and shakers in the Financial sector today.
5 Stocks With Strong Surprise — ASPN LOV GHDX FENG SSRI
This week, these five stocks have the best ratings in Surprise, one of the eight Fundamental Categories on Portfolio Grader.
1 – 10 of 240 results
